Moreover, unsaturated fatty acids (UFAs) have been shown to activate the IL-6/STAT3 pathway, resulting in upregulation of FGL1 expression, further contributing to NAFLD development [54] (Fig. 4). Here, FGL1 is linked to metabolic dysfunction-associated steatotic liver disease.